HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Ebeling Selected Research

beta Subunit Thyrotropin (Thyrotropin-beta)

10/2017Image analysis for TSH mRNA in situ hybridization in pituitary glands from rats with thyroid follicular cell hypertrophy after treatment with three different test compounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Ebeling Research Topics

Disease

5Neoplasms (Cancer)
12/2021 - 01/2011
4Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2019 - 11/2017
2Obesity
12/2019 - 01/2015
2Inflammation (Inflammations)
12/2019 - 09/2011
2Hypertrophy
10/2017 - 03/2009
2Tuberous Sclerosis (Bourneville's Disease)
09/2016 - 04/2016
2Body Weight (Weight, Body)
09/2011 - 03/2009
1Acquired Immunodeficiency Syndrome (AIDS)
12/2021
1Ataxia (Dyssynergia)
01/2021
1Neurodevelopmental Disorders
01/2021
1Angelman Syndrome (Syndrome, Angelman)
01/2021
1Diabetes Mellitus
12/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2019
1Hypothermia
06/2018
1Inborn Genetic Diseases (Disease, Hereditary)
09/2016
1Autism Spectrum Disorder
04/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2016
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2016
1Albuminuria
01/2016
1Diabetes Complications
01/2016
1Heart Diseases (Heart Disease)
01/2015
1Hypoxia (Hypoxemia)
03/2014
1Breast Neoplasms (Breast Cancer)
11/2013
1Duodenogastric Reflux
09/2011
1Infections
02/2010
1Human Influenza (Influenza)
02/2010
1Cardiovascular Diseases (Cardiovascular Disease)
01/2007
1Miyoshi myopathy
06/2006
1Muscular Dystrophies (Muscular Dystrophy)
06/2006
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
06/2006

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2011
3Messenger RNA (mRNA)IBA
10/2017 - 09/2011
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2018
2Phosphotransferases (Kinase)IBA
12/2019 - 11/2013
1Small Cytoplasmic RNAIBA
12/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021
1Insulin (Novolin)FDA Link
12/2019
1OligonucleotidesIBA
01/2019
1RisdiplamIBA
08/2018
1Transferrin Receptors (Transferrin Receptor)IBA
06/2018
1CytokinesIBA
06/2018
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
10/2017
1beta Subunit Thyrotropin (Thyrotropin-beta)IBA
10/2017
1trans-sodium crocetinate (crocetin)IBA
09/2016
1Mechanistic Target of Rapamycin Complex 1IBA
04/2016
1cathepsin SIBA
01/2016
1AlbuminsIBA
01/2016
1Peptide Hydrolases (Proteases)FDA Link
01/2016
1Lactic Acid (Lactate)FDA LinkGeneric
03/2014
1PhosphopeptidesIBA
11/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2013
1tyrosine receptor (receptor, tyrosine)IBA
11/2013
1Indomethacin (Indometacin)FDA LinkGeneric
09/2011
1Bile Acids and Salts (Bile Acids)IBA
09/2011
1InterferonsIBA
01/2011
1Biological ProductsIBA
01/2011
1Oseltamivir (Tamiflu)FDA Link
02/2010
1Chenodeoxycholic Acid (Chenix)FDA Link
03/2009
1Pharmaceutical PreparationsIBA
01/2007
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2007
1CholesterolIBA
01/2007
1DysferlinIBA
06/2006

Therapy/Procedure

2Therapeutics
11/2017 - 01/2015
1Aftercare (After-Treatment)
10/2017
1Treatment Delay
01/2016